Advertisement

Topics

Sequenom Company Profile

20:55 EDT 24th September 2017 | BioPortfolio

SEQUENOM is committed to providing the best genetic analysis products that translate genomic science into superior solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and potentially, clinical utility. The Company's proprietary MassARRAY® system is a high-performance DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations therein. The system is able to deliver reliable and specific data from complex biological samples and from genetic target material that is only available in trace amounts. The Company has exclusively licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY® system and other platforms.

Location

3595 John Hopkins Court
San Diego
CA
92121
United States of America

Contact

Phone: (858) 202-9000
Fax: 858 350 0344


News Articles [15 Associated News Articles listed on BioPortfolio]

Comparing Sequenom

Sequenom and Myriad Genetics are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, ri...

Sequenom Announces Participation At 31st Annual JP Morgan Healthcare Conference

SAN DIEGO, Jan. 2, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company'...

Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference

SAN DIEGO, May 8, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's part...

Sequenom Announces Participation At Two Upcoming Investor Conferences

SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's par...

Sequenom, Inc. Announces Date Of Third Quarter 2012 Financial Results And Conference Call

SAN DIEGO, Oct. 15, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will ...

Sequenom, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 04052017] Prices from USD $350

Sequenom, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sequenom, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report inclu...

Sequenom, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 11062017] Prices from USD $350

Sequenom, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sequenom, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report inclu...

Robbins Arroyo LLP Is Investigating the Directors and Officers of Sequenom, Inc. on Behalf of Shareholders

SAN DIEGO, Sept. 9, 2013 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Sequenom, Inc. (NASDAQ: SQNM) breached their fid...

Drugs and Medications [0 Results]

None

PubMed Articles [19 Associated PubMed Articles listed on BioPortfolio]

DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.

MicroRNA-874 (miR-874) is downregulated in several human cancers and has been suggested to be a tumor suppressor gene. However, the molecular mechanism of miR-874 downregulation in breast cancer has n...

Filaggrin gene polymorphism associated with Epstein-Barr virus-associated tumors in China.

Mutations of filaggrin gene (FLG) have been identified as the cause of ichthyosis vulgaris, while recently FLG mutations were found to be associated with gastric cancer. This study aimed to investigat...

Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study.

This study aimed to investigate whether there are specific polymorphisms within six genes (BRCA1, BRCA2, TP53, DAPK1, MMP9 promoter, and TOX3) that are associated with breast cancer among the Jordania...

Genetic variants in the plasminogen activator inhibitor-1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients.

Plasminogen activator inhibitor-1 (PAI-1) plays a crucial role in the process of lung injury, although its association with radiation pneumonitis (RP) is unclear. We hypothesized that genetic variants...

Association between single nucleotide polymorphisms in AKT1 and the risk of prostate cancer in the Chinese Han population.

AKT1, also known as v-akt murine thymoma viral oncogene homolog 1, is involved in the regulation of cell-survival and anti-apoptotic activities, which may affect the pathogenesis of various cancers. H...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is not a single disease, but a composite of heterogeneous subgroup. Accordingly, more sophisticated classification in ALL is essential to achieve further...

Companies [4 Associated Companies listed on BioPortfolio]

Sequenom, Inc.

Sequenom, Inc. (Nasdaq: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagn...

Sequenom

SEQUENOM is committed to providing the best genetic analysis products that translate genomic science into superior solutions for biomedical research, agricultural applications, molecular medicine and ...

Bionest Partners Inc.

Bionest Partners Inc. provides strategy consulting services exclusively for the life science industries to help pharmaceutical, biopharmaceutical, diagnostics, biotechnology, and ...

NewGene Limited

The demand for testing individuals for genetic disorders or cancers that have arisen from acquired genetic variations is growing year on year.  This is being driven by advances in medical genet...

More Information about "Sequenom" on BioPortfolio

We have published hundreds of Sequenom news stories on BioPortfolio along with dozens of Sequenom Clinical Trials and PubMed Articles about Sequenom for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sequenom Companies in our database. You can also find out about relevant Sequenom Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record